DefenAge Received Two US Patents For Melasma & Hair Growth
DefenAge® Skincare, manufacturer and distributor of revolutionary, evidence-based anti-aging products, announces today that the US Patent and Trademark Office grants two new patents for the use of Defensin-molecules for topical treatment of hair loss in skin affected by alopecia and of the hyperpigmented lesions of melasma
March 20, 2022
232 view(s) 
